- Report
- July 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1752EUR$2,000USD£1,520GBP
- Report
- August 2025
- 120 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- July 2024
- 200 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- November 2021
- 844 Pages
Global
From €4379EUR$5,000USD£3,801GBP
Interferon beta is a type of drug used to treat diseases of the central nervous system (CNS). It is a type of cytokine, a protein that helps regulate the immune system. Interferon beta is used to treat multiple sclerosis (MS), a chronic autoimmune disorder of the CNS. It is also used to treat other neurological conditions such as optic neuritis, transverse myelitis, and neuromyelitis optica. Interferon beta works by reducing inflammation and slowing the progression of MS.
Interferon beta is available in both injectable and oral forms. It is typically prescribed in combination with other medications to treat MS. Common side effects of interferon beta include flu-like symptoms, fatigue, and injection site reactions.
Companies in the interferon beta market include Biogen, Merck, Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more